180 related articles for article (PubMed ID: 27127888)
1. Functional networks of aging markers in the glomeruli of IgA nephropathy: a new therapeutic opportunity.
Jiang H; Liang L; Qin J; Lu Y; Li B; Wang Y; Lin C; Zhou Q; Feng S; Yip SH; Xu F; Lai EY; Wang J; Chen J
Oncotarget; 2016 Jun; 7(23):33616-26. PubMed ID: 27127888
[TBL] [Abstract][Full Text] [Related]
2. RNA-Seq profiling of microdissected glomeruli identifies potential biomarkers for human IgA nephropathy.
Park S; Yang SH; Jeong CW; Moon KC; Kim DK; Joo KW; Kim YS; Lee JW; Lee H
Am J Physiol Renal Physiol; 2020 Nov; 319(5):F809-F821. PubMed ID: 32954852
[TBL] [Abstract][Full Text] [Related]
3. Identification of potential biomarkers and therapeutic targets for human IgA nephropathy and hypertensive nephropathy by bioinformatics analysis.
Cui Y; Liu S; Cui W; Gao D; Zhou W; Luo P
Mol Med Rep; 2017 Sep; 16(3):3087-3094. PubMed ID: 28713898
[TBL] [Abstract][Full Text] [Related]
4. Unveiling biomarkers and therapeutic targets in IgA nephropathy through large-scale blood transcriptome analysis.
Gan T; Qu LX; Qu S; Qi YY; Zhang YM; Wang YN; Li Y; Liu LJ; Shi SF; Lv JC; Zhang H; Peng YJ; Zhou XJ
Int Immunopharmacol; 2024 May; 132():111905. PubMed ID: 38552291
[TBL] [Abstract][Full Text] [Related]
5. Transcriptomic and Proteomic Profiling Provides Insight into Mesangial Cell Function in IgA Nephropathy.
Liu P; Lassén E; Nair V; Berthier CC; Suguro M; Sihlbom C; Kretzler M; Betsholtz C; Haraldsson B; Ju W; Ebefors K; Nyström J
J Am Soc Nephrol; 2017 Oct; 28(10):2961-2972. PubMed ID: 28646076
[TBL] [Abstract][Full Text] [Related]
6. Mapping novel immunogenic epitopes in IgA nephropathy.
Woo SH; Sigdel TK; Dinh VT; Vu MT; Sarwal MM; Lafayette RA
Clin J Am Soc Nephrol; 2015 Mar; 10(3):372-81. PubMed ID: 25542908
[TBL] [Abstract][Full Text] [Related]
7. Identification of inflammatory biomarkers in IgA nephropathy using the NanoString technology: a validation study in Caucasians.
Gaumond L; Lamarche C; Beauchemin S; Henley N; Elftouh N; Gerarduzzi C; Laurin LP
Inflamm Res; 2024 Mar; 73(3):447-457. PubMed ID: 38291238
[TBL] [Abstract][Full Text] [Related]
8. Biomarker prediction for membranous nephropathy prognosis by microarray analysis.
Zhou G; Xin G; Zhang W; Zhang X
Nephrology (Carlton); 2019 May; 24(5):526-533. PubMed ID: 30084529
[TBL] [Abstract][Full Text] [Related]
9. Altered mRNA expression in renal biopsy tissue from patients with IgA nephropathy.
Waga I; Yamamoto J; Sasai H; Munger WE; Hogan SL; Preston GA; Sun HW; Jennette JC; Falk RJ; Alcorta DA
Kidney Int; 2003 Oct; 64(4):1253-64. PubMed ID: 12969143
[TBL] [Abstract][Full Text] [Related]
10. Analysis of glomerular anionic charge status in children with IgA nephropathy using confocal laser scanning microscopy.
Sakagami Y; Nakajima M; Takagawa K; Ueda T; Akazawa H; Maruhashi Y; Shimoyama H; Kamitsuji H; Yoshioka A
Nephron Clin Pract; 2004; 96(3):c96-104. PubMed ID: 15056992
[TBL] [Abstract][Full Text] [Related]
11. Molecular profiling in IgA nephropathy and focal and segmental glomerulosclerosis.
Tycová I; Hrubá P; Maixnerová D; Girmanová E; Mrázová P; Straňavová L; Zachoval R; Merta M; Slatinská J; Kollár M; Honsová E; Tesař V; Viklický O
Physiol Res; 2018 Mar; 67(1):93-105. PubMed ID: 29137483
[TBL] [Abstract][Full Text] [Related]
12. Identification and validation of glomerulotubular crosstalk genes mediating IgA nephropathy by integrated bioinformatics.
Bai Y; Li Y; Xi Y; Ma C
BMC Nephrol; 2022 Apr; 23(1):143. PubMed ID: 35418061
[TBL] [Abstract][Full Text] [Related]
13. Tissue-specific expression of renin-angiotensin system components in IgA nephropathy.
Miyake-Ogawa C; Miyazaki M; Abe K; Harada T; Ozono Y; Sakai H; Koji T; Kohno S
Am J Nephrol; 2005; 25(1):1-12. PubMed ID: 15644622
[TBL] [Abstract][Full Text] [Related]
14. Genome-wide analysis of microRNAs expression profiling in patients with primary IgA nephropathy.
Tan K; Chen J; Li W; Chen Y; Sui W; Zhang Y; Dai Y
Genome; 2013 Mar; 56(3):161-9. PubMed ID: 23659700
[TBL] [Abstract][Full Text] [Related]
15. Proteins induced by telomere dysfunction are associated with human IgA nephropathy.
Lu YY; Yang X; Chen WQ; Ju ZY; Shou ZF; Jin J; Zhang XH; Chen JH; Jiang H
J Zhejiang Univ Sci B; 2014 Jun; 15(6):566-74. PubMed ID: 24903994
[TBL] [Abstract][Full Text] [Related]
16. Mesangial cells from patients with IgA nephropathy have increased susceptibility to galactose-deficient IgA1.
Ebefors K; Liu P; Lassén E; Elvin J; Candemark E; Levan K; Haraldsson B; Nyström J
BMC Nephrol; 2016 Apr; 17():40. PubMed ID: 27044423
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-155-induced T lymphocyte subgroup drifting in IgA nephropathy.
Yang L; Zhang X; Peng W; Wei M; Qin W
Int Urol Nephrol; 2017 Feb; 49(2):353-361. PubMed ID: 27796698
[TBL] [Abstract][Full Text] [Related]
18. Activated innate immunity and the involvement of CX3CR1-fractalkine in promoting hematuria in patients with IgA nephropathy.
Cox SN; Sallustio F; Serino G; Loverre A; Pesce F; Gigante M; Zaza G; Stifanelli PF; Ancona N; Schena FP
Kidney Int; 2012 Sep; 82(5):548-60. PubMed ID: 22572859
[TBL] [Abstract][Full Text] [Related]
19. Identification and Validation of Prognostic Biomarkers Specifically Expressed in Macrophage in IgA Nephropathy Patients Based on Integrated Bioinformatics Analyses.
Ding Y; Li H; Xu L; Wang Y; Yang H
Front Mol Biosci; 2022; 9():884588. PubMed ID: 35601837
[No Abstract] [Full Text] [Related]
20. Fucose as a potential therapeutic molecule against the immune-mediated inflammation in IgA nepharopathy: An unrevealed link.
Qing J; Hu X; Li C; Song W; Tirichen H; Yaigoub H; Li Y
Front Immunol; 2022; 13():929138. PubMed ID: 36059518
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
